Healthcare India Podcast: Healthcare Technology That Moves EBITDA
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
When private equity evaluates a hospital group, what truly moves the EBITDA multiple — and what is just digital theatre?
In this episode, we go deep with Arvind Sivaramakrishnan, CTO for Asia Healthcare Holdings ,into how investors assess technology maturity during healthcare diligence. We unpack the difference between hygiene technologies and valuation-accelerating capabilities, and examine how digital infrastructure now influences deal outcomes.
We discuss:
Which tech capabilities tangibly improve valuation multiples
How investors assess data maturity, interoperability, and cyber risk
Why automation is becoming a margin stabiliser
The linkage between clinical improvement and enterprise value
The technologies likely to command a premium by 2030
If you are a CEO, CTO, founder, or healthcare investor, this conversation reframes digital strategy as an investment thesis — not an IT roadmap.